prednisolone has been researched along with Diabetes Insipidus, Neurogenic in 14 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Diabetes Insipidus, Neurogenic: A genetic or acquired polyuric disorder caused by a deficiency of VASOPRESSINS secreted by the NEUROHYPOPHYSIS. Clinical signs include the excretion of large volumes of dilute URINE; HYPERNATREMIA; THIRST; and polydipsia. Etiologies include HEAD TRAUMA; surgeries and diseases involving the HYPOTHALAMUS and the PITUITARY GLAND. This disorder may also be caused by mutations of genes such as ARVP encoding vasopressin and its corresponding neurophysin (NEUROPHYSINS).
Excerpt | Relevance | Reference |
---|---|---|
"The prednisolone dose was gradually decreased, and a dose of 5 mg/day had been maintained since 2004." | 1.37 | [Case of mixed connective tissue disease complicated with sarcoidosis and central diabetes insipidus]. ( Ito, D; Kadoya, H; Matsuda, J; Mori, D; Murata, H; Takeji, M; Yamauchi, A, 2011) |
"Diagnosis of a giant macroprolactinoma was made and cabergoline was started." | 1.35 | Misdiagnosis due to the hook effect in prolactin assay. ( Arda, N; Comlekci, A; Men, S; Yener, S; Yesil, S, 2008) |
"Although ocular sarcoidosis is often accompanied by secondary glaucoma or optic nerve atrophy, the progression of neurosarcoidosis can lead to visual field defects." | 1.34 | [Case of neurosarcoidosis with rapid visual field defect progression]. ( Asukata, Y; Hasumi, Y; Hayashi, K; Ishihara, M; Mizuki, N; Nakamura, S; Nishida, T, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (7.14) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (35.71) | 29.6817 |
2010's | 7 (50.00) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
Authors | Studies |
---|---|
Iwamoto, Y | 1 |
Mori, S | 1 |
Tatsumi, F | 1 |
Sugisaki, T | 1 |
Dan, K | 1 |
Katakura, Y | 1 |
Kimura, T | 1 |
Shimoda, M | 1 |
Nakanishi, S | 1 |
Mune, T | 1 |
Kaneto, H | 1 |
Kumar, M | 1 |
Menon, AS | 1 |
Iseda, I | 1 |
Hida, K | 1 |
Tone, A | 1 |
Tenta, M | 1 |
Shibata, Y | 1 |
Matsuo, K | 1 |
Yamadori, I | 1 |
Hashimoto, K | 2 |
Konomoto, T | 1 |
Tanaka, E | 1 |
Imamura, H | 1 |
Orita, M | 1 |
Sawada, H | 1 |
Nunoi, H | 1 |
Yener, S | 1 |
Comlekci, A | 1 |
Arda, N | 1 |
Men, S | 1 |
Yesil, S | 1 |
Inaba, H | 1 |
Suzuki, S | 1 |
Shigematsu, S | 1 |
Takei, M | 1 |
Miyamoto, T | 1 |
Takeda, T | 1 |
Yamauchi, K | 1 |
Hashizume, K | 1 |
Niramitmahapanya, S | 1 |
Deerochanawong, C | 1 |
Suwanbun, T | 1 |
Serirat, O | 1 |
Utrapichart, U | 1 |
Kalayanarooj, S | 1 |
Kuakpaetoon, T | 1 |
Matsuda, J | 1 |
Ito, D | 1 |
Mori, D | 1 |
Kadoya, H | 1 |
Murata, H | 1 |
Takeji, M | 1 |
Yamauchi, A | 1 |
Tanaka, K | 1 |
Yamamoto, M | 1 |
Okazaki, K | 1 |
Yamaguchi, T | 1 |
Sugimoto, T | 1 |
Funauchi, M | 1 |
Nozaki, Y | 1 |
Suk Yoo, B | 1 |
Ohno, M | 1 |
Kinoshita, K | 1 |
Kanamaru, A | 1 |
BROIDE, L | 1 |
Ogawa, N | 1 |
Takamatsu, T | 1 |
Miyake, T | 1 |
Sota, K | 1 |
Kato, Y | 1 |
Hasumi, Y | 1 |
Ishihara, M | 1 |
Asukata, Y | 1 |
Nishida, T | 1 |
Hayashi, K | 1 |
Nakamura, S | 1 |
Mizuki, N | 1 |
Vyas, V | 1 |
Shah, SA | 1 |
Patel, KM | 1 |
Parekh, BB | 1 |
Nath, SV | 1 |
Hussain, BM | 1 |
1 review available for prednisolone and Diabetes Insipidus, Neurogenic
Article | Year |
---|---|
Prednisolone markedly reduced serum IgG4 levels along with the improvement of pituitary mass and anterior pituitary function in a patient with IgG4-related infundibulo-hypophysitis.
Topics: Aged; Autoimmune Diseases; Diabetes Insipidus, Neurogenic; Humans; Hydrocortisone; Hypopituitarism; | 2014 |
13 other studies available for prednisolone and Diabetes Insipidus, Neurogenic
Article | Year |
---|---|
Central Diabetes Insipidus Due to IgG4-related Hypophysitis That Required over One Year to Reach the Final Diagnosis Due to Symptoms Being Masked by Sialadenitis.
Topics: Autoimmune Hypophysitis; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Diabetes Mellitus; Huma | 2022 |
Langerhans cell histiocytosis.
Topics: Antidiuretic Agents; Antineoplastic Agents; Biopsy; Child, Preschool; Deamino Arginine Vasopressin; | 2018 |
Nephrotic syndrome complicated by idiopathic central diabetes insipidus.
Topics: Anti-Inflammatory Agents; Arginine Vasopressin; Child; Deamino Arginine Vasopressin; Diabetes Insipi | 2014 |
Misdiagnosis due to the hook effect in prolactin assay.
Topics: Antineoplastic Agents; Cabergoline; Diabetes Insipidus, Neurogenic; Diagnostic Errors; Ergolines; Fe | 2008 |
Lymphocytic infundibuloneurohypophysitis: long-term follow-up of a case cured with glucocorticoid.
Topics: Aged; Antiemetics; Deamino Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Female; Humans; Mag | 2010 |
Langerhans' cell histiocytosis (LCH) in adolescence presented with central diabetes insipidus: a case report.
Topics: Antineoplastic Agents; Biopsy; Diabetes Insipidus, Neurogenic; Diagnosis, Differential; Drug Therapy | 2011 |
[Case of mixed connective tissue disease complicated with sarcoidosis and central diabetes insipidus].
Topics: Deamino Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Female; Humans; Middle Aged; Mixed Con | 2011 |
Partial improvement of anterior pituitary deficiency following steroid treatment in a patient with neurosarcoidosis accompanied by central diabetes insipidus.
Topics: Central Nervous System Diseases; Diabetes Insipidus, Neurogenic; Female; Follicle Stimulating Hormon | 2012 |
Microscopic polyangitis as a possible cause of diabetes insipidus.
Topics: Diabetes Insipidus, Neurogenic; Female; Glucocorticoids; Humans; Magnetic Resonance Imaging; Middle | 2002 |
[Diabetogenic action of prednisolone and its effect of diuresis in diabetes insipidus].
Topics: Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Diabetes Mellitus; Diuresis; Diuretics; Humans; | 1957 |
[Masked diabetes insipidus manifested by administration of adrenocortical steroid hormone for erythroderma].
Topics: Administration, Intranasal; Adrenal Insufficiency; Aged; Aged, 80 and over; Deamino Arginine Vasopre | 2004 |
[Case of neurosarcoidosis with rapid visual field defect progression].
Topics: Adult; Central Nervous System Diseases; Deamino Arginine Vasopressin; Diabetes Insipidus, Neurogenic | 2007 |
Acute lymphocytic leukemia CNS disease presenting as central diabetes insipidus.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain; Chlorambucil; Deamino Arginine Vasopre | 2002 |